Brain Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For breast cancer patient participants:

• Women who have been diagnosed with invasive breast cancer that has not spread to other parts of the body (stages I through IIIC)
• People who are scheduled to start a chemotherapy treatment plan using the drugs Adriamycin and Cytoxan
• People who have never received chemotherapy before
• People who are able to speak and read English
• People aged 21 or older
• People who are willing to sign a written consent form

For control participants (people without breast cancer who take part for comparison):

• Women who are within 5 years of age of a breast cancer participant in the trial
• People who are able to speak and read English
• People aged 21 or older
• People who are willing to sign a written consent form

Who may not be able to join:

For breast cancer patient participants:

• People who are currently in hospital, or who have been hospitalised in the past year due to a mental health condition
• People who have been diagnosed with a disease that causes the brain or nervous system to break down over time, such as Alzheimer's or Parkinson's disease
• People who have a condition affecting the brain or central nervous system, such as multiple sclerosis or a movement disorder
• People who have had a mini-stroke (TIA) or stroke within the past year, or who still have symptoms from a past TIA or stroke (confirm with trial site)
• People who are scheduled to receive radiation treatment at the same time as chemotherapy
• People who are colorblind

For control participants:

• People who are currently in hospital, or who have been hospitalised in the past year due to a mental health condition
• People who have been diagnosed with a disease that causes the brain or nervous system to break down over time, such as Alzheimer's or Parkinson's disease
• People who have a condition affecting the brain or central nervous system, such as multiple sclerosis or a movement disorder
• People who have had a mini-stroke (TIA) or stroke within the past year, or who still have symptoms from a past TIA or stroke (confirm with trial site)
• People who have previously been diagnosed with cancer or received chemotherapy
• People who are colorblind

For the optional brain scan sub-study:

• MRI safety screening is required to determine whether participation in the optional scanning portion of the study is appropriate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.